BioSpace News Archive

Job Trends

Pharma Growth Across the Globe: AstraZeneca, BeiGene and More

It’s been a busy week so far, with new discovery facilities launched in the biotech space.

November 23, 2021
·
3 min read
·
Vanessa Doctor, RN
Policy

Lockdowns in Europe Won’t be Duplicated in US and More COVID-19 News

The U.S. CDC has issued new travel warnings as surges of COVID-19 continue throughout the country and the world. For that and other COVID-19 news, read below.

November 23, 2021
·
4 min read
·
Mark Terry
FDA

FDA Approves First Therapy to Treat Ultra-Rare Cancer with Low Survival Rates

Shares of Aadi Bioscience were up more than 25% in premarket trading after announcing the FDA greenlit its treatment for a rare and aggressive form of cancer that disproportionately affects women.

November 23, 2021
·
2 min read
·
Alex Keown
Drug Development

Tonix Cleared to Propel Migraine Therapy into Phase II

Tonix expects to begin enrollment in the trial for TNX-1900, an intranasal potentiated oxytocin, during the second half of 2022.

November 23, 2021
·
2 min read
·
Heather McKenzie
Policy

USDA Cautiously Optimistic About SARS-CoV-2 Spread in Wildlife Populations

A preprint in bioRxiv from Penn State showed SARS-CoV-2 was detected in 33% (94) of the 283 white-tailed deer tested in Iowa between November 23, 2020 and January 10, 2021.

November 23, 2021
·
4 min read
·
Gail Dutton
Business

GSK Goes All-In on NASH in $1 Billion Arrowhead Pact

ARO-HSD will be evaluated in a Phase I/II trial that will assess the safety, tolerability, pharmacokinetics, and pharmacodynamic effects of its ability to target HSD17B13 as a treatment for NASH.

November 23, 2021
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Research Roundup: Masking Cuts COVID-19 Risk in Half and More Research News

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones from this week.

November 23, 2021
·
5 min read
·
Mark Terry
Business

Vaccibody Has a New Name and a Fresh Partnership with Regeneron

Vaccibody has changed its name to Nykode Therapeutics. “Nykode” means “new code,” which plays on the potential of the company to generate novel codes and innovative patient therapies.

November 23, 2021
·
3 min read
·
Mark Terry
Policy

With Life-Saving Meds on the Line, FDA Doubles Down on Inspection Goal

The U.S. FDA is making up for Covid-lost time this year, doubling the goal for FY 2021 domestic surveillance inspections for food and medical manufacturing facilities.

November 23, 2021
·
2 min read
·
Kate Goodwin
Policy

Elizabeth Holmes Takes the Stand in Self-Defense

After months of ongoing testimony from various whistleblowers and investors, Elizabeth Holmes, Theranos founder and CEO, has finally taken the witness stand in her fraud trial.

November 23, 2021
·
3 min read
·
Alex Keown